[1]EuropeanJournalofMedicinalChemistry,2011,vol.46,p.4634-4641
[1]Patent:US2017/283427,2017,A1.Locationinpatent:Paragraph0186;0187;0194;0195
1159824-79-9
1219182-45-2
157116-68-2
30377-07-2
137-16-6
7596-88-5
1313730-08-3 | Bisphenol A-13C12 β-D-Glucuronide | AA009DZB
1211542-18-5 | tert-Butyl 4-(5-hydroxypyridin-2-yl)piperazine-1-carboxylate | AA009E5N | MFCD18259530
1219804-19-9 | Cyromazine-d4 | AA009EE3 | MFCD11616807
1266843-37-1 | Hexahydro-7-Methyl-1-(phenylMethyl)-1H-1,4-diazepine | AA009EN2 | MFCD19286034
122147-95-9 | 4-METHYLUMBELLIFERYL B-D-CHITOBIOSE PERACETATE | AA009EV7 | MFCD09841038
134612-80-9 | (4-Hydroxy-3-methoxy-5-nitrophenyl)(p-tolyl)methanone | AA009F1F | MFCD12545750
1398065-74-1 | Monooctyl Phthalate-d4 | AA009F9P
1329792-51-9 | 4-AMinophenazone-d3 | AA009FI9
1219798-78-3 | 1,2-Phenylenediamine-d8 | AA009FP9 | MFCD06658611
1212257-18-5 | Fmoc-L-cyclopropylglycine | AA009G4N | MFCD06659145